berberine has been researched along with Anxiety in 7 studies
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
Excerpt | Relevance | Reference |
---|---|---|
"Psoriasis is a common inflammatory skin disorder, which can be associated with psychological disorders, such as anxiety and depression." | 5.72 | Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice. ( Choi, MJ; Nguyen, LTH; Shin, HM; Yang, IJ, 2022) |
"Berberine (BBR) has shown efficacy in the treatment of diseases such as postmenopausal osteoporosis, obesity, and type 2 diabetes through regulating the gut microbiota." | 5.62 | Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota. ( Duan, L; Fang, Y; He, M; Jia, Q; Ma, S; Song, L; Sun, Q; Wang, Y; Zhang, J; Zhu, S, 2021) |
"The present study aimed to investigate the effects of berberine (BRB) on spatial and learning memory, anxiety, acetylcholinesterase activity and cell death in an experimental model of intracerebroventricular streptozotocin (ICV-STZ) induced sporadic Alzheimer's-like dementia." | 3.83 | Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death. ( Abdalla, FH; Adefegha, SA; Baldissarelli, J; da Silva Bernardi, J; de Andrade, CM; de Oliveira, JS; Dornelles, GL; Lenz, LS; Magni, LP; Palma, TV; Pillat, MM; Rubin, MA; Signor, C, 2016) |
"Psoriasis is a common inflammatory skin disorder, which can be associated with psychological disorders, such as anxiety and depression." | 1.72 | Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice. ( Choi, MJ; Nguyen, LTH; Shin, HM; Yang, IJ, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Nguyen, LTH | 1 |
Choi, MJ | 1 |
Shin, HM | 1 |
Yang, IJ | 1 |
Fang, Y | 1 |
Zhang, J | 2 |
Zhu, S | 1 |
He, M | 1 |
Ma, S | 1 |
Jia, Q | 1 |
Sun, Q | 1 |
Song, L | 1 |
Wang, Y | 1 |
Duan, L | 1 |
Alavijeh, MM | 1 |
Vaezi, G | 1 |
Khaksari, M | 1 |
Hojati, V | 1 |
Vaziri, Z | 1 |
Abbassian, H | 1 |
Sheibani, V | 1 |
Haghani, M | 1 |
Nazeri, M | 1 |
Aghaei, I | 1 |
Shabani, M | 1 |
de Oliveira, JS | 1 |
Abdalla, FH | 1 |
Dornelles, GL | 1 |
Adefegha, SA | 1 |
Palma, TV | 1 |
Signor, C | 1 |
da Silva Bernardi, J | 1 |
Baldissarelli, J | 1 |
Lenz, LS | 1 |
Magni, LP | 1 |
Rubin, MA | 1 |
Pillat, MM | 1 |
de Andrade, CM | 1 |
Mi, G | 1 |
Liu, S | 1 |
Liang, H | 1 |
Gao, Y | 1 |
Li, N | 1 |
Yu, B | 1 |
Yang, H | 1 |
Yang, Z | 1 |
Peng, WH | 1 |
Wu, CR | 1 |
Chen, CS | 1 |
Chen, CF | 1 |
Leu, ZC | 1 |
Hsieh, MT | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Double-blind, Randomized, Placebo-controlled Trial of Berberine as an Adjuvant to Treat Antipsychotic-induced Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders[NCT02983188] | Phase 2/Phase 3 | 113 participants (Actual) | Interventional | 2018-04-25 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
7 other studies available for berberine and Anxiety
Article | Year |
---|---|
Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice.
Topics: Animals; Anxiety; Behavior, Animal; Berberine; Imiquimod; Male; Mice; Mice, Inbred BALB C; Psoriasis | 2022 |
Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
Topics: Animals; Anxiety; Berberine; Equol; Fecal Microbiota Transplantation; Female; Gastrointestinal Micro | 2021 |
Berberine hydrochloride attenuates voluntary methamphetamine consumption and anxiety-like behaviors via modulation of oxytocin receptors in methamphetamine addicted rats.
Topics: Amphetamine-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Berberine; C | 2019 |
The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor.
Topics: Animals; Anxiety; Berberine; Essential Tremor; Exploratory Behavior; Gait; Harmaline; Male; Motor Sk | 2015 |
Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antibiotics, Antineoplastic; Anxiety; Berberine; B | 2016 |
Levo-Tetrahydroberberrubine Produces Anxiolytic-Like Effects in Mice through the 5-HT1A Receptor.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Berberine; Male; Mice; Mice, Inbred ICR; Ra | 2017 |
Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Berberine; Buspirone; Diazepam; Dose-Response Relationship, D | 2004 |